Incyte (INCY) Beats Q1 Earnings and Revenue Estimates [Yahoo! Finance]
Incyte Corporation (INCY)
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
incyte.com/ir/investor-overview.aspx
Company Research
Source: Yahoo! Finance
This compares to earnings of $1.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +31.29%. A quarter ago, it was expected that this specialty drugmaker would post earnings of $1.94 per share when it actually produced earnings of $1.8, delivering a surprise of -7.22%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Incyte, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.27 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 4.21%. This compares to year-ago revenues of $1.05 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Incyte
Show less
Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
News
- Incyte (INCY) had its price target raised by Stifel Nicolaus from $120.00 to $123.00. They now have a "buy" rating on the stock.MarketBeat
- Earnings To Watch: Amgen (AMGN) Reports Q1 Results Tomorrow [Yahoo! Finance]Yahoo! Finance
- Incyte (INCY) had its "market perform" rating reaffirmed by Oppenheimer Holdings, Inc..MarketBeat
- Incyte to Present at Upcoming Investor ConferencesBusiness Wire
- Incyte Corp (INCY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Promising ... [Yahoo! Finance]Yahoo! Finance
INCY
Earnings
- 4/28/26 - Beat
INCY
Sec Filings
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form ARS
- 4/28/26 - Form DEF
- INCY's page on the SEC website